Ivermectin is a widely used anthelmintic drug whose nematocidal mechanism is incompletely understood. We have used Caenorhabditis elegans as a model system to understand ivermectin's effects. We found that the M3 neurons of the C.elegans pharynx form fast inhibitory glutamatergic neuromuscular synapses. avr-15, a gene that confers ivermectin sensitivity on worms, is necessary postsynaptically for a functional M3 synapse and for the hyperpolarizing effect of glutamate on pharyngeal muscle. avr-15 encodes two alternatively spliced channel subunits that share ligand binding and transmembrane domains and are members of the family of glutamate-gated chloride channel subunits. An avr-15-encoded subunit forms a homomeric channel that is ivermectin-sensitive and glutamate-gated. These results indicate that: (i) an ivermectin-sensitive chloride channel mediates fast inhibitory glutamatergic neuromuscular transmission; and (ii) a nematocidal property of ivermectin derives from its activity as an agonist of glutamate-gated chloride channels in essential excitable cells such as those of the pharynx.
Introduction
Ivermectin is a potent anthelmintic drug that is widely used to treat nematode infections in livestock (Campbell, 1989) but is also the drug of choice in the treatment of onchocerciasis (river blindness) (Liu and Weller, 1996) . The target of ivermectin is supposed to be glutamategated chloride channels. Ivermectin increases chloride permeability in insect neurons (Lees and Beadle, 1986) and muscles (Duce and Scott, 1985) as well as in crustacean muscle (Fritz et al., 1979; Mellin et al., 1983) . Ivermectin opens chloride channels in outside-out patches from Ascaris suum (nematode) muscle membrane (Martin and Pennington, 1989) . When applied to outside-out patches of crayfish muscle, ivermectin and glutamate appear to increase the open time of the same chloride channel (Zufall et al., 1989) . A cDNA has been cloned from Caenorhabditis elegans which encodes a protein, GluClα, that forms homomeric ivermectin-sensitive chloride channels when expressed in Xenopus oocytes (Cully et al., 1994) . In addition, this ivermectin-sensitive channel can associate with a glutamate-gated channel subunit from C.elegans, GluClβ, to form a channel that is both ivermectin-sensitive and glutamate-gated (Cully et al., 1994) .
However, there is no direct evidence linking GluClα to the in vivo effects of ivermectin on worms. Although GluClα has been proposed to mediate neurotransmission at inhibitory glutamatergic synapses, GluClα must associate with GluClβ in order to respond to glutamate (Cully et al., 1994) . There is no evidence that these subunits associate or are even co-expressed in the organism and no inhibitory glutamatergic synapses have been characterized in nematodes (Geary et al., 1992) . Determining the role of GluClα is complicated further by indications that avermectins potentiate gating of GABA-gated channels by GABA (Pong and Wang, 1982; Sigel and Baur, 1987) or reduce the mean channel current (Martin and Pennington, 1989) . Since GABA-gated channels are expressed in nematodes (see Martin, 1993; McIntire et al., 1993a,b) they are also potentially relevant targets of avermectins.
Caenorhabditis elegans is a useful system in which to understand the mechanism of ivermectin's action in nematodes. Ivermectin prevents growth of C.elegans at a concentration of Ͻ10 ng/ml (J.Dent, unpublished observation) and induces paralysis at~20 ng/ml (Arena et al., 1995) . One obvious effect of ivermectin on C.elegans and other nematodes is that it inhibits pharyngeal pumping (Bottjer and Bone, 1985; Avery and Horvitz, 1990; Geary et al., 1993) . In order for C.elegans to eat, the pharynx, a neuromuscular organ, must pump rhythmically with a cycle of contraction and relaxation. The pharynx forms a tube made up of 20 muscle cells of eight anatomical types and 20 neurons of 14 anatomical types (see Figure 6A ; Albertson and Thomson, 1976) . Contraction of the radially oriented pharyngeal myofibrils pulls the walls of the anterior (corpus) pharyngeal lumen apart, opening the pharynx. Liquid and the suspended bacterial food are thereby sucked into the worm. Muscle relaxation results in the rapid collapse of the walls of the lumen, forcing liquid out of the anterior pharynx while trapping the suspended bacteria. Peristalsis of the isthmus transports bacteria to the terminal bulb where they are ground to a digestible pulp and deposited in the intestine.
The timing of pharyngeal muscle relaxation is important for proper trapping of bacteria (Avery, 1993a) . A bilaterally symmetric pair of pharyngeal motor neurons, the M3s, which synapse on the corpus muscle (Albertson and Thomson, 1976 ; see Figure 6A ), modulate the timing of relaxation. The M3s generate inhibitory postsynaptic potentials (IPSPs) in the contracted pharyngeal muscle. When the M3 neurons are ablated with a laser, the IPSPs disappear and the muscle contractions have a longer average duration (Avery, 1993b; Raizen and Avery, 1994) . Although GABAergic neurotransmission exists in C.elegans (McIntire et al., 1993a,b) , the M3 neurons are clearly not GABAergic since they do not stain with antibodies to GABA (McIntire et al., 1993b) and mutants that lack GABAergic neurotransmission retain M3-generated IPSPs (Raizen and Avery, 1994) .
Since ivermectin inhibits pharyngeal pumping in C.elegans and the nematode expresses ivermectin-and glutamate-sensitive channels, we hypothesized that the inhibitory postsynaptic potentials generated by the M3 motor neuron might be the result of fast inhibitory glutamatergic neurotransmission mediated by an ivermectinsensitive chloride channel. We confirmed our hypothesis by showing that: (i) the pharynx responds to iontophoretically applied glutamate by hyperpolarizing; (ii) the response to glutamate is absent in avr-15, a mutant that lacks M3 IPSPs and that confers synthetic ivermectin resistance on worms; and (iii) avr-15 codes for a protein that is a member of the family of ivermectin-sensitive and glutamate-gated chloride channel subunits. These results demonstrate the role of glutamate-gated channels in the nematocidal mechanism of ivermectin and identify the pharynx as an essential organ that is targeted by ivermectin. The results also suggest that the presence of multiple ivermectin targets may explain the absence of widespread ivermectin resistance.
Results
Iontophoretic application of glutamate to pharyngeal muscle mimics the effects of M3 activity If the M3 neurons are glutamatergic, then iontophoretic application of glutamate directly to the pharyngeal muscle should mimic the ability of the M3 neurons to hyperpolarize the muscle and shorten the duration of muscle contraction during a pump. To test this, we used an exposed pharynx preparation. To expose the pharynx, the worm was bisected at the pharyngeo-intestinal valve. The remaining cuticle surrounding the pharynx was retracted, exposing the terminal bulb and the posterior corpus muscles which are innervated by the M3 neurons. In the proper saline solution, the pharynx continues to pump normally and produces a normal electropharyngeogram (EPG) (Davis et al., 1995) . Application of glutamate iontophoretically to corpus muscle beginning immediately after the initiation of a pump substantially shortened the pump duration ( Figure 1A and B). Thus, glutamate hastens hyperpolarization of contracted, depolarized pharyngeal muscle. Since photolytic release of caged glutamate onto the pharyngeal muscle during a pump produced IPSP-like spikes in an EPG (H.Li, W.Denk, L.Avery and G.Hess, unpublished observation), presumably iontophoresed glutamate is also producing IPSPs, but these are so large that they prematurely return the pharyngeal muscle to the resting potential. Iontophoretic application of aspartate had no effect on pump duration, ruling out the possibility that decreased pump duration is an electrical stimulus artifact ( Figure  1B) . In a blind comparison of six aspartate samples and six glutamate samples, we were able to identify the glutamate samples by their effect on pump duration (P Ͻ 0.005).
To exclude the possibility that the glutamate acted on the muscle indirectly by stimulating the M3 neurons, we 5868 ablated the M3 neurons with a laser. In their absence, the muscle still responded to glutamate ( Figure 1B) . To determine whether a chloride channel mediated the effect of glutamate on the pharyngeal muscle, we altered the external chloride concentration. If the effect of glutamate on the pharyngeal muscle is mediated by a chloride channel, then a sufficient reduction in the external chloride concentration should cause glutamate to depolarize the muscle. When the chloride concentration was reduced from 153 mM to 14 mM, glutamate extended pump duration; raising the chloride concentration restored the ability of glutamate to shorten pump duration ( Figure 1C ).
avr-15 is necessary for M3 activity and confers ivermectin sensitivity
In the course of a screen for starved mutants that have abnormal EPGs, we found one, ad1051, that lacked M3 IPSPs ( Figure 2A ) and was slightly starved but otherwise appeared normal. We showed that ad1051 mapped under the deficiency nDf42 on chromosome V and that ad1051 did not complement avr-15(nr395), indicating that ad1051 is an allele of avr-15. Furthermore, the phenotype of avr-15(ad1051)/nDf42 was not obviously worse than that of the avr-15(ad1051) homozygote, consistent with the possibility that ad1051 is a null allele.
Alleles of avr-15 were first identified because they confer recessive synthetic resistance to ivermectin in combination with mutations in other avr genes (Rand and Johnson, 1995; C.D.Johnson, unpublished observation cited in Anderson, 1995) . Single mutant strains homozygous for avr-15 mutations (including ad1051) display little or no resistance. To determine whether avr-15(ad1051) can confer synthetic resistance, we selected for mutants in an avr-15(ad1051) background that were resistant to 10 ng/ml ivermectin. Mutants were identified at a rate of Ͼ1:1700 per haploid genome, which is consistent with the frequency for loss-of-function alleles. The resistance genes from one resistant strain were mapped. Mutations in two genes were necessary for resistance, avr-15(ad1051) and a gene on chromosome I [avr(ad1302)]. Thus, avr-15(ad1051) confers synthetic resistance to ivermectin in conjunction with at least one other gene. avr-15 is necessary for the pharyngeal muscle to respond to iontophoretically applied glutamate Since avr-15 confers sensitivity to ivermectin and ivermectin is thought to be an agonist of glutamate-gated chloride channels, one possibility was that avr-15 encodes a subunit of an ivermectin-sensitive glutamate-gated channel. If avr-15 encodes a glutamate receptor subunit present in the postsynaptic muscle membrane, then pharynxes from avr-15 mutants should not respond to iontophoretically applied glutamate. As a control in these experiments, we used a previously identified mutant, eat-4, that also lacks M3 activity but is thought to act presynaptically (R.Y.N.Lee, personal communication). In a blind comparison, we were able to identify the genotypes of six avr-15(ad1051) and six eat-4(ad572) worms because the pharynxes of avr-15 mutants did not respond to glutamate, whereas the pharynxes from eat-4 mutants did (P Ͻ 0.005; Figure  2B ). Thus, avr-15 acts postsynaptically in the pharyngeal Fig. 1 . Effects of iontophoresis of glutamate on pharyngeal pump duration. (A) Electropharyngeogram (EPG) of a wild-type exposed pharynx and of a wild-type pharynx to which glutamate was applied iontophoretically during the 100 ms period indicated by the bar. The EPG corresponds approximately to the time derivative of the pharyngeal muscle membrane potential (Raizen and Avery, 1994) . The first upward spike (E) marks the depolarization of the muscle membrane that initiates muscle contraction. The large downward spike (R) marks the repolarization of the corpus muscle that precedes corpus muscle relaxation. During the period of depolarization, inhibitory postsynaptic potentials (IPSPs) from the M3 motor neurons are evident. The iontophoretic application of glutamate shortens the duration of the action potential to 50 ms. (B) Effect of glutamate and aspartate on average pump duration in exposed wild-type pharynxes and in exposed pharynxes lacking M3 neurons. Ten pumps were measured from each pharynx; five pumps with no delay between the E spike and application of glutamate or aspartate (ϩ), alternating with five pumps during which the application of glutamate or aspartate was delayed until 400 ms after the E spike (-). The duration of the pump was determined by the time between the E and R spikes. Error bars indicate 1 SEM. (C) The effect of glutamate in low-chloride solution. Each wild-type pharynx was tested for the ability of glutamate to shorten the pump duration in 14 mM ('low') chloride solution and retested after raising the chloride concentration to 84 mM ('high'). '**' and '*' indicate that the difference between the ϩ and -bars is statistically significant at P Ͻ 0.005 and P Ͻ 0.01 respectively. muscle whereas eat-4 acts presynaptically, presumably in the M3 neuron itself.
Alternatively spliced chloride channel subunits map near avr-15
Our results indicated that avr-15 might encode a glutamateand ivermectin-sensitive chloride channel subunit. To test this idea, we used PCR to generate a 2.2 kb GluClα (Cully et al., 1994) genomic DNA clone that was used to probe a YAC grid. The GluClα probe hybridized strongly to three overlapping YACs (Y55D7, Y56A6 and Y42B4; Figure 3A ). These YACs presumably represent the map position of GluClα, which is not consistent with the map position of avr-15. In addition, the GluClα probe hybridized weakly to three overlapping YACs (Y47E2, Y55E8 and Y53F11; Figure 3A ) that map under nDf42, ϩ) indicates glutamate was applied immediately after the E spike; (-) indicates the glutamate pulse was delayed 400 ms after the E spike. Error bars indicate SEM. '**' indicates that the difference between the ϩ and -bars is statistically significant at P Ͻ0.005.
consistent with the map position of avr-15. The region where these YACs overlap is covered by the cosmid K10B8 ( Figure 3B ). We used GluClα to probe Southern blots of K10B8 restriction digests; the regions of K10B8 identified by the GluClα probe were sequenced and found to encode open reading frames with significant similarity to GluClα. Two alternatively spliced cDNAs of 2.2 kb and 1.7 kb were identified that correspond to chloride channel subunits encoded by the GluClα-like gene on K10B8. Bands whose sizes corresponded to that of the two cDNAs were identified on a Northern blot. The 1.7 kb cDNA appeared to be expressed at a level at least twice that of the 2.2 kb cDNA ( Figure 4 ).
GluClα2 belongs to the family of ivermectinsensitive glutamate-gated chloride channel subunits
The transcripts encoded by K10B8 contain open reading frames that predict mature proteins of 459 amino acids (mol. wt~53 kDa) and 630 amino acids (mol. wt~72 kDa; Figure 5 ). When compared with a protein database, the highest degree of similarity is to GluClα, followed by GluClβ, the Drosophila glutamate-gated chloride channel and then the mammalian glycine-gated channel subunits (α and β). Between amino acids 45 and 379-the extracellular ligand-binding domain through the third transmembrane domain, a region characterized by few homology gapsthe putative open reading frame has 83% amino acid identity to GluClα but only 54% identity to GluClβ and 53% identity to the Drosophila glutamate-gated channel ( Figure 5 ). The alternatively spliced transcripts share the exons encoding the putative transmembrane and ligand binding domains which are the regions of the channel subunits that are homologous to other ligand-gated channel subunits. The non-shared domains, which are part of the putative extracellular domain, consist of 23 amino acids (1.7 kb transcript) and 202 amino acids (2.2 kb transcript) and have no significant similarity to anything in the database. The predicted proteins from both transcripts begin with consensus signal peptides that are predicted to 5870 be cleaved at amino acids 23 (1.7 kb) and 27 (2.2 kb; von Heijne, 1986) . Since the homology to GluClα is comparable with the level of homology among sequences within a subclass of GABA A or glycine channel subunits (70-80%; Grenningloh et al., 1990; Bechade et al., 1994; Macdonald and Olsen, 1994) whereas the homology to GluClβ is comparable with the homology among GABA A or glycine channel subclasses, the chloride channel subunits encoded by K10B8 and GluClα appear to define a subclass of the ivermectin-sensitive chloride channel subunits. Hence, we will refer to the channel subunits encoded by the K10B8 as GluClα2A (2.2 kb) and GluClα2B (1.7 kb) and the original GluClα subunit as GluClα1.
GluClα2A and B have features typical of ligandgated chloride channels ( Figure 5 ). The four putative transmembrane domains are the most conserved regions within this family of proteins (see also Cully et al., 1994 for a characterization of regions of homology between the glutamate-gated channel subunits and other ligand-gated chloride channels). GluClα2A contains three predicted extracellular N-linked glycosylation sites, one of which, N397, is conserved on both GluClα1 and GluClβ. There is a predicted phosphorylation site in the intracellular domain between transmembrane regions three and four, T524, that is conserved in GluClα1. Cysteines in the extracellular domain that are conserved in glycine-and GABA-gated channels are also present in GluClα2. An unusual feature of GluClα2A is its large,~420 amino acid extracellular domain characterized by a 35 residue-long acidic stretch that contains 21 aspartate or glutamate residues ( Figure 5 ).
avr-15 encodes GluClα2
Based on the electrophysiological results, we predicted that avr-15 would be expressed in the pharyngeal muscles onto which M3 synapses. A 6 kb DNA fragment that encodes the first three exons of GluClα2A fused to green fluorescent protein (GFP) was used to transform worms. The transformed animals exhibited fluorescence in all of avr-15-encoded chloride channel the muscles of the metacorpus (pm4) and the isthmus (pm5), precisely those muscles onto which M3 synapses (Albertson and Thomson, 1976 ; Figure 6A and B). The GFP staining of pharyngeal muscle began shortly before hatching and persisted throughout adulthood. Strong staining was also seen in a few neurons of the head, including RMED, RMEV and the bilaterally symmetric RMGs (data not shown). Weak staining was seen in unidentified ventrally located neurons contributing to the dorsal and ventral sublateral nerve cords. Two ventral cord neurons near the anus stain consistently, namely DA9 and a more anteriorly located neuron that is likely to be VA12. Thus, the GluClα2A promoter is active in pharyngeal muscle as well as some motor neurons, suggesting that GluClα2A is also expressed in these cells.
If avr-15 encodes GluClα2A or B, then avr-15(ad1051) would be expected to contain a disabling mutation in the chloride channel open reading frame. The GluClα2 gene from avr-15(ad1051) worms was sequenced and found to contain a G→A transition in the third position of the W271 codon (of GluClα2A) which creates an opal stop codon. Because the ad1051 nonsense mutation occurs relatively early in the gene, before the four transmembrane domains, and since it is in an exon that is shared by both transcripts, ad1051 is likely to be a null allele of both gene products. A Northern blot of avr-15(ad1051) worms shows that the levels of both transcripts are reduced at least 2-fold and 4-fold for GluClα2A and GluClα2B respectively (Figure 4 ). There is a system in C.elegans which degrades RNAs that contain nonsense mutations and which would account for the reduction in the levels of the GluClα2A and GluClα2B transcripts (Pulak and Anderson, 1993) .
When used to stably transform avr-15(ad1051) worms, the cosmid K10B8 restores M3 IPSPs to the pharyngeal muscle (data not shown). To confirm that GluClα2 is the relevant transcript from K10B8, we generated a construct that places the GluClα2A cDNA under the transcriptional control of the myo-2 promoter. The myo-2 promoter specifically drives expression in a subset of pharyngeal muscles including pm4, the muscle onto which M3 synapses (Okkema et al., 1993) . When stably transformed into the ivermectin-resistant strain DA1302 [avr(ad1302) I; avr-15(ad1051) V], the myo-2::GluClα2A construct also restores M3 IPSPs to the pharyngeal muscle (data not shown).
Finally, to determine whether GluClα2 also rescues the ivermectin resistance phenotype, we tested the ivermectin resistance of the avr(ad1302) I; avr-15(ad1051) V; myo-2:: GluClα2A strain. Since, in the myo-2::GluClα2A-carrying strain, the extrachromosomal arrays formed by exogenous DNA are only transmitted to~20% of the progeny of transformed worms, we tested mixed populations of transformed and non-transformed worms for sensitivity to ivermectin. When a mixed population of worms was grown on 10 ng/ml ivermectin, none of the adult worms expressed the roller phenotype of the dominant rol-6 cotransformation marker, indicating that worms carrying myo-2::GluClα2A had become ivermectin-sensitive and were arrested as larvae (data not shown).
GluClα2A forms a homomeric ivermectin-sensitive and glutamate-gated channel
In order to clarify the role of the GluClα2A subunit in glutamate-gating and ivermectin sensitivity, we expressed the subunit in Xenopus oocytes. Either RNA transcribed
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from the GluClα2A open reading frame or water was injected into oocytes and allowed to express. RNA-injected but not water-injected oocytes exhibited reversible, glutamate-gated currents that desensitized rapidly in a concentration-dependent manner ( Figure 7A ). The channels responded to as little as 100 μM glutamate but did not respond to 1 mM glycine or 1 mM GABA (data not shown). Maximal responses to glutamate at 10 mM were obtained 30 s after the glutamate had been washed out, indicating the recovery from desensitization was also rapid. A concentration-response curve indicated an EC 50 of 2.0 Ϯ 0.3 mM glutamate with an estimated Hill coefficient of 1.5 ( Figure 7A ; see Materials and methods for an explanation of calculations).
When ivermectin was applied at a concentration of 10 μM, a slowly desensitizing current was generated which was not reversed when the bath solution was replaced by Ringers ( Figure 7B ). The maximal ivermectininduced current was on average 30 (Ϯ6)-fold greater (n ϭ 4) than the maximal current obtained from previous exposure of the same oocyte to 10 mM glutamate. At a concentration of 0.5 mM, ibotenate produced a response that was 6 Ϯ 2% of the maximal response from 10 mM glutamate (n ϭ 6). The GluClα2B cDNA encodes a channel that responds to both glutamate and ivermectin with similar kinetics to those exhibited by GluClα2A (data not shown).
An I-V curve of the GluClα2A channel after exposure to 10 μM ivermectin is shown in Figure 7C . In Ringers, the current is outwardly rectifying and the average reversal potential is -20 Ϯ 3 mV (n ϭ 5), consistent with a calculated Nernst potential for chloride of -19 mV assuming 50 mM internal chloride (Kusano et al., 1982) . When the sodium chloride in the Ringers was replaced by sodium gluconate, the reversal potential shifted positively to over ϩ30 mV (calculated reversal potential for 8 mM external chloride is ϩ46 mV). Thus, GluClα2 forms a glutamateand ivermectin-sensitive chloride channel.
Discussion
AVR-15/GluClα2 is a member of the family of glutamate-gated chloride channel subunits The family of glutamate-gated chloride channel subunits has many parallels to the other ligand-gated chloride channels. The fact that GluClα2 shares such a high level of identity with GluClα1, comparable with the homology shared by GABA A or glycine receptor subunits within a single class (α or β for glycine channels, Bechade et al., 1994 ; α, β, γ, δ or ρ for GABA A channels, Macdonald and Olsen, 1994) , suggests that the family of glutamategated chloride channel subunits is similarly diverse and that further members of the α and/or β classes as well as new classes of subunits may remain to be identified. A cursory examination of the C.elegans genome that has been sequenced so far (~70% of the genome) indicates the presence of a multitude of potential chloride channel genes (J.Dent, unpublished observation). The fact that ivermectin resistance is synthetic suggests the possibility that loss-of-function mutations in a gene(s) encoding other ivermectin-sensitive channel subunits may confer, in combination with avr-15, high-level ivermectin resistance. Since avr(ad1302) maps to chromosome I and GluClα1 Fig. 5 . Alignment of GluClα2 with other ligand-gated chloride channels subunits. The shaded amino acids are identical to GluClα2A. The bold W indicates the position of the opal nonsense mutation in ad1051. The '*' indicates putative N-linked glycosylation sites. The 'ϩ' indicates cysteine residues in the extracellular domain that are conserved among glutamate-or glycine-gated chloride channels. 'π' indicates a potential PKA and PKC phosphorylation site conserved between GluClα2 and GluClα1. The acidic region of the putative extracellular domain is underlined. GluClα1 and GluClβ are C.elegans ivermectin-and glutamate-gated channel subunits (Cully et al., 1994) ; Dros GluCl is a Drosophila melanogaster ivermectinand glutamate-gated subunit ; rGlyα2 is a rat glycine channel subunit, . The sequence of the alternatively spliced amino-terminal domain present in GluClα2B is shown at the bottom. The arrows indicate the points at which the amino acids sequences of the two proteins converge. Sequences were aligned using CLUSTAL W (Thompson et al., 1994) and annotated using DNA DRAW. is on chromosome V, there may be a third GluClα subunit encoded by avr(ad1302).
Presumably, as for the other ligand-gated channels (Macdonald and Olsen, 1994) , the subunits from different classes of the GluCl family assemble into a pentameric channel. The stoichiometry for GABA-and glycinegated channels is thought to be (2α)(2β)(γ) and (3α)(2β) respectively (Bechade et al., 1994; Chang et al., 1996) . It has been shown that GluClα1 and GluClβ can associate to form channels in Xenopus oocytes (Cully et al., 1994) . Since GluClα2 forms a homomeric channel that responds to both glutamate and ivermectin, it could in principle act as a homomer to mediate M3 neurotransmission. However, we think this is unlikely because: (i) GluClα2A is relatively unresponsive to glutamate (EC 50 ϭ 2 mM) compared with GluClβ (EC 50 ϭ 380 μM; Cully et al., 1994) and the Drosophila glutamate-gated channel (EC 50 ϭ 23 μM; Cully et al., 1996) ; and (ii) we found that the patterns of expression of the GluClα2A and GluClβ promoters overlap in the pharyngeal muscle pm4, suggesting that the two subunits associate to form the M3 receptor (Laughton et al., 1995) . The fact that mutations in avr-15 result in the absence of M3 neurotransmission and the absence of a pharyngeal response to glutamate indicates that, if there are other subunits of the M3 receptor, such as GluClβ, they cannot form a functional channel without GluClα2.
GluClα2A combines properties seen in other glutamategated chloride channel subunits: (i) it responds to both glutamate and ivermectin; (ii) the ivermectin-induced response partially densensitizes; and (iii) the glutamate response desensitizes rapidly. Etter et al. (1996) showed that a single amino acid change (T308A or G) in the M2 transmembrane domain of GluClα1 generated a channel subunit that exhibited behaviors very similar to those exhibited by GluClα2A. The GluCl channel from Drosophila also responds to both ligands and has a rapidly desensitizing glutamate current . Thus, small changes in channel structure can affect the linkage of ligand binding to channel gating as well as the kinetics of desensitization. Interestingly, T308 is conserved between GluClα2 and GluClα1.
Like some subunits of the GABA A and glycine receptor families, GluClα2 is alternatively spliced. Splice variants of mammalian GABA γ2 and glycine α1 channel subunits remove a potential phosphorylation site in the intracellular domain Macdonald and Olsen, 1994 ). An α2 glycine receptor subunit has two splice variants that differ in an exon coding for part of the extracellular domain . Although GluClα2 has a potential phosphorylation site in the intracellular loop domain that is conserved with GluClα1, there is no evidence that it is affected by alternative splicing. Rather, the GluClα2A splice variant contains a large extracellular domain not found in any known ligandgated chloride channel subunits. The role of the large extracellular domain in GluClα2A is not clear, but it does not appear to affect gating by glutamate or ivermectin since GluClα2B and GluClα2A respond similarly to these ligands (J.Dent, unpublished observation). It includes a highly acidic domain and is predicted to be substantially α-helical (Chou and Fasman, 1974) . Thus, it may interact with other proteins, perhaps as part of a synaptic localization mechanism.
M3s are fast inhibitory glutamatergic neurons
We present the following evidence that M3 is glutamatergic: (i) When applied to the exposed pharynx, glutamate mimics the effect of the M3 neuron and shortens the duration of the muscle contraction during a pump. (ii) avr-15, a mutant that lacks M3-generated IPSPs, is also insensitive to iontophoretically applied glutamate. (iii) avr-15 acts in the pharyngeal muscle, as indicated by the fact that expression under the myo-2 promoter rescues M3-generated IPSPs. (iv) avr-15 encodes a protein, GluClα2A, which forms a homomeric glutamate-gated chloride channel. Taken together, these data indicate that the avr-15-encoded chloride channel subunit is part of a glutamategated channel that is expressed in the pharyngeal muscle and responds to glutamate released by the M3 neurons at neuromuscular synapses. This is the first demonstration of a fast inhibitory glutamatergic synapse in nematodes (Geary et al., 1993) .
The inhibitory, hyperpolarizing effects of glutamate have been demonstrated for neurons of crustaceans (Bidaut, 1980; Eisen and Marder, 1982; Marder and Eisen, 1984) , insects (Wafford and Sattelle, 1989) and molluscs (Gerschenfeld and Lasansky, 1964; Walker et al., 1971; Cottrell et al., 1972; Oomura et al., 1974) and glutamate has also been shown to have an inhibitory effect on crustacean (Lingle and Marder, 1981) and insect muscle (Cull-Candy, 1976; Delgado et al., 1989) . The effects of glutamate are mediated by chloride and/or potassium and both conductances are often blocked by picrotoxin. In contrast, although vertebrates exhibit a slow inhibitory glutamatergic neurotransmission mediated by metabotropic glutamate receptors, fast glutamatergic neuro-transmission appears to be strictly excitatory and is mediated by a different class of channels (Nakanishi, 1992) . The specificity of ivermectin for channels that mediate inhibitory glutamatergic neurotransmission may in part explain why it is tolerated so well by vertebrates.
GluClα2 confers ivermectin sensitivity on C.elegans
Our results demonstrate that a nematocidal activity of ivermectin is a result of the ability of ivermectin to act as an agonist of chloride channels. Ivermectin appears to act as an agonist by increasing the open time of the receptor (Martin and Pennington, 1989; Zufall et al., 1989) . Thus, a mutant that is resistant to ivermectin would be expected to contain a mutation that reduces the activity of the ivermectin-sensitive channel, i.e. a loss-of-function mutation. This is consistent with the molecular evidence that avr-15(ad1051) is a null allele. Since GluClα2 forms a homomeric channel that responds to ivermectin, it must itself bind ivermectin rather than merely being necessary for the formation of an ivermectin-sensitive channel.
In order for ivermectin to be lethal, the chloride permeability that it generates must inhibit essential cells or organs. Previous results are consistent with the idea that ivermectin exerts its lethality via its ability to starve worms by inhibiting pharyngeal pumping. Ivermectin inhibited pumping in C.elegans and other nematodes (Bottjer and Bone, 1985; Avery and Horvitz, 1990; Geary et al., 1993) . C.elegans eggs that are placed in ivermectin hatch, but the larvae never grow (J.Dent, unpublished observation); they arrest in the first larval stage, which is a phenotype of worms that are unable to feed (Avery and Horvitz, 1987) . However, these results do not rule out indirect effects on the pharynx, which is bathed in the pseudocoelomic fluid and is therefore sensitive to humoral effects and the general health of the worm (L.Avery, unpublished observation). The fact that GluClα2 confers ivermectin sensitivity even when its expression is restricted to pharyngeal muscle using the myo-2 promoter supports the idea that ivermectin directly inhibits pharyngeal pumping which is sufficient to kill the worm by starvation.
One of the mysteries of ivermectin action that our results may help begin to address is why ivermectin is larvicidal but not adulticidal (Dreyer et al., 1995) . If the relevant site of action in parasitic nematodes is also the pharynx, then it may be that growing larvae need to ingest food more efficiently that adults, who have already stored up reserves of food and are not growing. A related question is what role the ability of ivermectin to paralyze worms plays in its nematocidal mechanism (Arena et al., 1995) . We showed that GluClα2A appears to be expressed in the nervous system, specifically in motor neurons, and ivermectin may therefore interfere with locomotion via its interaction with receptors expressed on neurons. Severe paralysis has surprisingly little effect on the viability of C.elegans grown in the laboratory. Whether paralysis is likely substantially to affect the viability of a parasitic nematode and whether it is likely preferentially to affect larvae probably depends on the particulars of that nematode's life-style.
Carl Johnson first showed that ivermectin resistance is synthetic-in other words, there must be mutations in two genes simultaneously for worms to exhibit high-level 5876 (Ͼ10-fold) resistance (Rand and Johnson, 1995;  C.D.Johnson, unpublished observation cited in Anderson, 1995) . We have confirmed this observation by isolating ivermectin-resistant worms from an avr-15 background. The nature of the other ivermectin-resistant genes is presently unclear; one possibility is that some encode other ivermectin-sensitive channel subunits. As mentioned above, there appear to be multiple C.elegans genes encoding putative chloride channel subunits in addition to the genes for GluClα1 and α2 (J.Dent, unpublished observation). Interestingly, when exposed pharynxes of avr-15(ad1051) worms are treated with ivermectin, they continue pumping, indicating that ivermectin's other target is extrapharyngeal (J.Dent, unpublished observation).
In spite of ivermectin's widespread use, only isolated cases of resistance have been reported in the field (Clark et al., 1995) , possibly because parasitic helminths must also acquire multiple mutations to become resistant. A better understanding of ivermectin resistance in C.elegans and in parasitic helminths may indicate strategies for the design of other anthelmintic drugs that do not suffer from the development of resistance in treated populations. Our results suggest that targeting drugs to the protein products of multigene families may be useful in preventing resistance.
Materials and methods

Care of C.elegans
Worms were raised using standard techniques (Sulston and Hodgkin, 1988) and fed Escherichia coli strain HB101 or DA837 (Davis et al., 1995) . The wild-type strain was Bristol strain N2. The following mutant strains were used: DA1051 avr-15(ad1051) V, CB1489 him-8(e1489) IV, DA1052 him-8(e1489) IV; avr-15(ad1051) V, NS378 avr-15(nr395 him-8(e1489) IV; avr-15(nr395) V, DA438 bli-4(e937) I; rol-6(e187) II; daf-2(e1368ts) vab-7(e1562) III; unc-31(e928) IV; dpy-11(e224) V; lon-2(e678) X, DA1302 and RC301. avr-15(ad1051) was isolated in an RC301 background by standard ethyl methanesulfonate mutagenesis techniques (Anderson, 1995) using the clonal starvation screen described previously (Avery, 1993a) with the following modification: worms were screened on the E.coli strain DA837 to enhance the starvation phenotype and starved mutants underwent a secondary screen in which only mutants with abnormal EPGs were kept. To test for complementation between ad1051 and avr-15, a him-8(e1489); avr-15(ad1051) double was constructed (DA1052) and males from this strain were mated to NS378 [avr-15(nr395) ]. F 1 male progeny were examined by EPG and found to lack M3 IPSPs. Similarly, a him-8(e1489); avr-15(nr395) double was constructed (DA1068) and males from this strain and from DA1052 were mated to the nDf42 strain MT5813. Non-Unc F 1 male progeny from these crosses were scored by EPG and found to lack M3 IPSPs. Ivermectin-resistant strains were isolated by EMS mutagenesis of avr-15(ad1051), growth of 10 separate pools on normal plates, followed by selection of F 2 eggs on plates containing 1% DMSO/~10 ng/ml ivermectin. Only one resistant worm was isolated from each pool. The worms were 2ϫ outcrossed to N2 by mating N2 males to the resistant strain and then mating the male progeny to N2 hermaphrodites. The F 2 eggs from that cross were reselected for ivermectin resistance on plates containing either 10 or 100 ng/ml ivermectin. Mapping was performed by crossing males from the resistant strain into DA438 and selecting the F 2 eggs on 10 or 100 ng/ml ivermectin.
Genetics
Electrophysiology
Electropharyngeograms (EPGs) were performed as described by Raizen and Avery (1994) in Dent's saline in the absence of serotonin. EPGs of exposed pharynxes were performed and analyzed as described by Davis et al. (1995) . Iontophoresis pipettes were pulled avr-15-encoded chloride channel on a Sutter P87 pipette puller and filled with a solution of 300 mM sodium glutamate, 50 mM carboxyfluorescein, neutralized to pH 7.0 with potassium hydroxide. The iontophoresis pipette was connected to an electrically isolated current source of our own design (schematic available on request). The resistance of the pipette was typically 50-150 MΩ. The carboxyfluorescein allowed us to see the iontophoretic pulse and confirm that the pipette was working properly. A retaining current of 1-10 nA was applied and the pulse current was typically -25 to -45 nA. The tip of the iontophoresis pipette was maneuvered to a point just posterior of the metacorpus at the approximate position of the M3 neurons (Albertson and Thomson, 1976 ; at more posterior positions, the glutamate was ineffective). The EPG trace of the exposed pharynx was fed into a Labview (National Instruments) virtual instrument (ACCTRIG written by M.W.Davis, available on request) which recorded the trace, detected the E spike of the EPG, and sent a command voltage to the current source. The current source generated the iontophoretic pulse. The glutamate and aspartate results were obtained in a blind trial. Six tubes of iontophoresis solution containing glutamate and six tubes containing aspartate were coded and tested for their effect on pump length. Some negatives (samples that had no effect on the pharynx) had to be re-tested to obtain a total of six positives, indicating that false negatives can occur. We never saw false positives. Since we cannot distinguish lack of effect from a false negative, some of the aspartate data included in the graph may be the result of false negatives. The effect of chloride concentration was tested by dissecting six worms into Dent's saline in which the sodium chloride was replaced with sodium gluconate. The same pharynxes were re-tested after replacing one-half of the buffer with normal Dent's saline. Pumps that extended beyond the 3-s recording window were treated as 3 s long. The data in Figure  2B were collected as part of a blind test comparing eat-4 with avr-15 mutants. The blind test was performed by coding six plates of avr-15(ad1051) worms and six plates of eat-4(ad572) worms. The mutant worms were grown on HB101 bacteria to mask their starvation phenotype (Davis et al., 1995) and appeared indistinguishable from each other. Some negatives were retested until the sixth positive was found. As noted for the aspartate data in Figure 2B , some of the avr-15 data included in the graph may be the result of false negatives. In all figures, a one-tailed Mann-Whitney U-test was used to determine statistical significance of the difference between the (-) and (ϩ) bars in each category.
Laser ablation
The M3 neurons of six wild type worms were killed by ablating the neurons with a laser using the protocol described in Raizen and Avery (1994;  see also Bargmann and Avery, 1995) . A sampling of the laser kills were verified by noting the absence of M3 activity in the EPG of operated worms.
Molecular biology
All molecular biology was performed according to standard methods as described in Sambrook et al. (1989) . All plasmid subcloning was into pBluescript KS(ϩ) (Stratagene, La Jolla, CA). A 2.2 kb GluClα1 genomic fragment was generated by PCR of DNA from wild-type worms using the primers GCTTCCGGTACCCCTCAATACTGCATAAATT-GGC and CCATGGGAGCTCTAAAATAATACGTTCTGCTGGCC and was subcloned. The identity of this clone was confirmed by partial sequencing using the PCR primers. The GluClα1 fragment was used to probe a C.elegans YAC grid. A weakly hybridizing signal to the overlapping YACs Y53F11, Y55E8 and Y47E2 identified K10B8 as a cosmid likely to contain DNA encoding the hybridizing sequence. Southern blots of a restriction digest of K10B8 identified a 4 kb BamHIHindIII fragment that hybridized to GluClα1. The BamHI-HindIII fragment was subcloned and both strands sequenced with Sequenase Version 2.0 (United States Biochemicals, Cleveland, OH) on deletions generated by the ExoIII/S1 method (Henikoff, 1987) . Customized sequencing primers were used to fill in the gaps. The GluClα1 clone was used to probe 480 000 plaques from a mixed-stage C.elegans cDNA library (Stratagene, La Jolla, CA). The primary and secondary plaques were reprobed with a~1 kb XbaI-BamHI K10B8 fragment using the T7 and T3 pBluescript primers to generate a PCR probe. The excised cDNAs in pBluescript SK -were generated by co-transfection of the isolated plaques with helper phage. The longest cDNA, gluA1, was ExoIII/S1 deleted and sequenced on one strand. We generated a probe corresponding to the~600 bp at the 5Ј end of gluA1 by PCR using the T3 primer and the primer CTGTGTCAGATGTTTGAGGT. When used to probe restriction digests of K10B8, the 5Ј gluA1 probe hybridized to a~1.5 kb XhoI-PstI fragment and an adjoining~6 kb PstI-SacI fragment 5877 on Southern blots. These fragments were subcloned, ExoIII/S1 deleted and partially sequenced on both strands by ABI DNA sequencer using dye terminator reactions.
RNA was isolated from N2 and DA1051 worms using RNA Stat-60 (Tel-Test B, Friendswood, TX) and poly(A) ϩ selected using oligo(dT) columns (5Ј-3Ј, Boulder, CO). The RNA was run on a formaldehyde gel and blotted. A double-stranded probe was generated by PCR of gluA1 cDNA using CCCCATATGATAGGTCGATTGCGGAGAGGCT ('oo-5') and AAGGTGCTCCAGAATTTCTGT ('cds-3'). The bands were quantitated using a Molecular Dynamics (Sunnyvale, CA) model 300 densitometer and ImageQuant software. A t-test was used to calculate the minimum intensity ratio of Northern bands over background. The ratio of the 2.2 kb band to the 1.7 kb band was calculated based on the intensity of the two bands on the Northern, normalizing for the actin loading controls. 5Ј RACE was performed to identify the 5Ј ends of the two transcripts using the 5Ј RACE kit (Gibco-BRL, Gaithersburg, MD). 100 ng poly(A) ϩ RNA was reverse transcribed using the 'cds-3' primer. We identified the 5Ј end of the 1.7 kb transcript by amplifying the cDNA with a primer corresponding to the SL-1 trans-spliced leader sequence ('SL1-Bam'; Krause, 1995) and GCTCTAGAGTTGTTCAATTGGTAC-ATGT, cloning into BamHI and XbaI sites of Bluescript KSϩ and sequencing. The 5Ј end of the larger transcript was identified by dC tailing the cDNA and amplifying with an anchored primer and GTTGATGTTGCGGGTTCAACT. The PCR product was diluted and amplified with the 'universal amplification' primer and CAUCAUCA-UCAUGGAACAAGATGAAGCCTCT where U is deoxyuridine. The product was cloned using the pAMP system (Gibco-BRL) and sequenced.
solutions containing ivermectin. Recording electrodes were filled with 3 M KCl and the bath electrode was connected via a 3 M KCl agar bridge. Solutions of glutamate or ivermectin in Ringers were applied to oocytes in a Warner Instruments (Hamden, CT) RC-24 perfusion chamber. Data were acquired and analyzed as described under Electrophysiology; some data were analyzed with Axograph software (Axon Instruments). To generate the concentration-response curve, curves from five different oocytes were fitted to the equation:
where I max is the maximal response, [D] is the concentration of glutamate, EC 50 is the glutamate concentration producing a half-maximal effect, and h is the Hill coefficient. I max , EC 50 and h were free parameters. The curves were then normalized to the estimated I max . The EC 50 from the five separate curves were averaged to generate the estimate of the EC 50 with SEM (see Results). To generate I-V curves, current generated by a 3-s voltage clamp from -80 to ϩ30 mV before drug application was subtracted from the current resulting from a post-application voltage clamp. For chloride substitution, the bath Ringers was replaced by Ringers made with Na gluconate instead of NaCl (final chloride concentration 7.8 mM). K10B8 and myo-2:: gluA1cDNA at a concentration of 1 μg/ml were microinjected into the syncytial gonads of adult hermaphrodites according to standard procedures (Mello and Fire, 1995) . The co-transfection marker rol-6 contained on the pRAK3 plasmid (Davis et al., 1995) was co-injected at a concentration of 70 μg/ml and transformants were identified by the roller phenotype.
Transformation
Ivermectin sensitivity assay NGMSR plates (Avery, 1993a) containing 1% DMSO and various concentrations of ivermectin were poured and spotted with E.coli strain HB101. Eggs were isolated from gravid adult hermaphrodites by the alkaline bleach method (Lewis and Fleming, 1995) , resuspended in M9 buffer, and~100 eggs were placed on the bacterial lawn of the ivermectincontaining plates. The number of worms reaching adulthood, as determined by the presence of eggs in the uterus, was counted periodically for 2 weeks. If the strain was resistant to ivermectin, then Ͼ50 worms grew to adulthood. If the strain was sensitive, then all worms were arrested as larvae. Approximately 200 eggs from the avr(ad1302); avr-15(ad1051); Ex [myo-2: :gluA1cDNA] strain were placed on each plate and the number of adult rollers was counted after 4 days.
